◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
KAKEN PHARMACEUTICAL CO.,LTD. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2025Mar 31, 2025FY 2024Mar 31, 2024FY 2023Mar 31, 2023FY 2022Mar 31, 2022FY 2021Mar 31, 2021
+Revenue 94.0B 72.0B 73.0B 76.0B 75.0B
Revenue Growth % 30.5% -1.3% -4.0% 1.4% --
+Operating Income 21.0B 9.5B 8.0B 17.1B 17.8B
Operating Margin % 22.4% 13.2% 11.0% 22.4% 23.7%
Non Operating Income 701.0M 543.0M 780.0M 543.0M 484.0M
Non Operating Expenses 456.0M 106.0M 51.0M 66.0M 50.0M
Ordinary Income 21.3B 10.0B 8.7B 17.5B 18.2B
Income Before Taxes 19.4B 9.8B 6.8B 13.9B 18.7B
Income Taxes 5.5B 1.8B 1.4B 4.3B 5.3B
+Net Income 13.9B 8.0B 5.4B 9.5B 13.4B
Net Margin % 14.8% 11.1% 7.5% 12.6% 17.9%
Eps 365.42 212.67 144.80 251.43 347.37
Depreciation Amortization 2.5B 2.6B 2.5B 2.5B 2.3B
Line ItemFY 2025Mar 31, 2025FY 2024Mar 31, 2024FY 2023Mar 31, 2023FY 2022Mar 31, 2022FY 2021Mar 31, 2021
Cash And Deposits 54.1B 50.6B 59.6B 61.0B 63.7B
Current Assets 111.4B 107.0B 109.9B 110.6B 113.7B
Property Plant Equipment 27.6B 25.4B 25.5B 25.7B 25.0B
Noncurrent Assets 79.0B 64.6B 56.4B 54.6B 49.7B
Total Assets 190.4B 171.6B 166.3B 165.2B 163.3B
Current Liabilities 30.4B 19.0B 20.8B 19.0B 21.3B
Total Liabilities 37.8B 27.9B 29.5B 26.9B 27.1B
Retained Earnings 135.2B 128.5B 126.1B 126.3B 122.5B
Total Equity 152.6B 143.8B 136.8B 138.3B 136.3B
Equity Ratio 0.80 0.84 0.82 0.83 0.83
Book Value Per Share 3,974 3,796 3,636 3,642 3,556
Num Employees 1,126 1,135 1,130 1,164 1,215
Roe 0.09 0.06 0.04 0.07 0.10
Line ItemFY 2025Mar 31, 2025FY 2024Mar 31, 2024FY 2023Mar 31, 2023FY 2022Mar 31, 2022FY 2021Mar 31, 2021
Operating Cash Flow 29.8B 2.6B 9.3B 13.3B 14.4B
Investing Cash Flow -19.6B -5.9B -2.6B -7.9B -1.6B
Financing Cash Flow -5.4B -5.7B -7.0B -8.1B -8.8B
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...